C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
08/2011
08/25/2011	US20110207739 Novel 1, 2-Disubstituted Amido-anthraquinone Derivatives, Preparation Method and application thereof
08/25/2011	US20110207730 Ion channel modulating compounds and uses thereof
08/25/2011	US20110207726 Inhibitors of Human Cathepsin L, Cathepsin B, and Cathepsin S
08/25/2011	US20110207714 Serotonin receptor modulators
08/25/2011	US20110207709 Modulators of serotonin receptor
08/24/2011	EP2358707A2 Compositions and methods for treatment of renin-angiotensin aldosterone system (raas)-related disorders
08/24/2011	EP2358672A1 N-substituted pyrrolidonium ionic liquids with expanded linker
08/24/2011	EP2358671A1 N-substituted pyrrolidonium ionic liquids
08/24/2011	EP2358670A2 Novel compounds
08/24/2011	EP1836164B1 11c-labeled benzyl-lactam compounds and their use as imaging agents
08/24/2011	EP1485353B1 New inhibitors of histone deacetylase
08/24/2011	EP1331922B1 Photo-labile pro-fragrance conjugates
08/24/2011	CN102162995A Photoresist composition
08/24/2011	CN102161656A Caspase inhibitors and uses thereof
08/24/2011	CN102161607A Method for preparing fluorine-containing aromatic compound
08/24/2011	CN102161546A Method for processing production effluent of maleimide compound
08/24/2011	CN101721720B Nitroimidazole-amino acid compound nuclide hypoxic contrast agent and precursor thereof
08/24/2011	CN101693684B Method for preparing 4-hydroxylethylpyrrolidone-2-acetamide
08/23/2011	US8003809 Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
08/23/2011	US8003808 3-hydrazino-2,5-dioxopyrrolidine-3-carboxylates, process for production of the same, and use of the same
08/23/2011	US8003791 Boronic ester and acid compounds, synthesis and uses
08/23/2011	US8003784 Cyanopyrrole containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same
08/18/2011	WO2011100227A1 Benzylpyrrolidinone derivatives as modulators of chemokine receptor activity
08/18/2011	WO2011098776A1 5-ht receptor modulators
08/18/2011	WO2011098440A2 Biphenyl substituted cyclical keto-enols
08/18/2011	WO2011098433A1 Cyclic keto-enols for therapy
08/18/2011	WO2011098398A1 Substituted pyrrolidine-2-carboxamides
08/18/2011	WO2011097717A1 Synthesis of bicyclic compounds and method for their use as therapeutic agents
08/18/2011	WO2011047192A3 Protected amine labels and use in detecting analytes
08/18/2011	US20110201825 Method for Producing Fluorosulfuric Acid Ester
08/18/2011	US20110201807 3-hydrazino-2,5-dioxopyrrolidine-3-carboxylate, process for production of the same, and use of the same
08/18/2011	US20110201583 Guanidine-containing compounds useful as muscarinic receptor antagonists
08/18/2011	CA2789806A1 5-ht receptor modulators
08/18/2011	CA2789551A1 Cyclic keto-enols for therapy
08/18/2011	CA2789344A1 Synthesis of bicyclic compounds and method for their use as therapeutic agents
08/18/2011	CA2788236A1 Substituted pyrrolidine-2-carboxamides
08/17/2011	EP2357168A1 Method for producing fluorosulfuric acid ester
08/17/2011	EP2356092A1 Biosynthetically generated pyrroline-carboxy-lysine and site specific protein modifications via chemical derivatization of pyrroline-carboxy-lysine and pyrrolysine residues
08/17/2011	EP2356091A2 Substituted amido phenoxybenzamides
08/17/2011	EP2094656B1 P<0}{0pyrrol derivatives, preparation and use of the same in therapy<0}
08/17/2011	EP0853618B1 Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) n- (aminoiminomethyl)phenylalkyl -azaheterocyclylamide compounds
08/17/2011	CN1871214B Process for the production of lactams
08/17/2011	CN102159553A Targeted nitroxide agents
08/17/2011	CN102159540A Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides
08/17/2011	CN102159311A Method for continuous production of amine using aluminium-copper catalyst
08/17/2011	CN102159207A Substituted pyrrolidine-2-carboxamides
08/17/2011	CN102153539A 3-aminopyrrolidine derivatives as modulators of chemokine receptors
08/17/2011	CN102153515A N,N'-bis-substituted urea Raf kinase inhibitors and preparation method and application thereof
08/17/2011	CN101570461B Greening synthetic method of polysubstituted pyrrole
08/17/2011	CN101497580B HIV-1 inhibitor 2-pyrrolidinone derivative, as well as synthesizing method and use thereof
08/17/2011	CN101184728B Peptide deformylase (PDF) inhibitors 4
08/16/2011	US7999111 Reacting an onium halide or carboxylate with a symmetrically substituted dialkyl sulfite or with an asymmetrically substituted dialkyl sulfite; 1-hexyl-3-methylimidazolium chloride and dimethyl sulfite; 1-Hexyl-3-methylimidazolium methanesulfonate
08/16/2011	US7999000 N-(2-amino-phenyl)-acrylamides
08/16/2011	US7998999 Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
08/16/2011	US7998959 Modulators of 11-β hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
08/16/2011	CA2480275C Statin therapy for enhancing cognitive maintenance
08/11/2011	WO2011096377A1 Pyrrole compound
08/11/2011	WO2011095802A1 Hplc method for analyzing sunitinib
08/11/2011	WO2011095452A1 Aryl benzylamine compounds
08/11/2011	WO2011094890A1 Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
08/11/2011	WO2011012322A9 Synthesis and use of vildagliptin for the preparation of pharmaceutical dosage forms
08/11/2011	US20110195967 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them
08/11/2011	US20110195929 Compounds for the treatment of flaviviral infections
08/11/2011	US20110195842 2,4,6-Phenyl-Substituted Cyclic Ketoenols
08/10/2011	EP2354124A2 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives
08/10/2011	EP2354120A1 Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
08/10/2011	EP2265580B1 Novel method for the production of sulphonylpyrroles as hdac inhibitors
08/10/2011	EP2190815B1 Pyrrolidine aryl-ether as nk3 receptor antagonists
08/10/2011	CN102149714A Novel tricyclic derivatives, process for the preparation thereof and pharmaceutical compositions containing same
08/10/2011	CN102149708A Pyrrolidin-2-ones as HDM2 ligands
08/10/2011	CN102149680A Nitrogen-containing aromatic heterocyclyl compound
08/10/2011	CN102149679A Pyrrolin-2-ylamino compounds for combating animal pests
08/10/2011	CN102149678A Novel ortho-aminoanilides for the treatment of cancer
08/10/2011	CN102149676A Monoaryl aminotetralines
08/10/2011	CN102146055A N-alkylpyridine-L-proline salt chiral ionic liquid and preparation method thereof
08/10/2011	CN102146053A 2-phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity for the treatment of inflammatory or immunological disorders
08/10/2011	CN102145304A Preparation of loaded Grubbs catalyst and application of loaded Grubbs catalyst
08/10/2011	CN101671289B Preparation method of 1, 2-di(2-pyrryl)-ethyldione
08/09/2011	US7994350 Process for continuously preparing N-ethyl-2-pyrrolidone (NEP)
08/09/2011	US7994344 Intermediates for the production of optically active cyclopropylamine derivatives and process for the production of the intermediates
08/09/2011	US7994343 Process for the production of atorvastatin calcium in amorphous form
08/09/2011	US7994342 Method for producing optically active succinimide compound
08/09/2011	US7994312 Synthetic route to ABCD-porphyrins
08/09/2011	US7994311 Fluorescent chemosensors for metals based on dipyrrins
08/09/2011	US7994209 3-phenoxymethylpyrrolidine compounds
08/09/2011	US7994176 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
08/09/2011	US7994093 Heterocyclocarboxamide derivatives
08/09/2011	CA2538938C Process for preparing 2-oxo-1-pyrrolidine derivatives
08/09/2011	CA2512000C Selective estrogen receptor modulator
08/09/2011	CA2487297C The use of substituted cyanopyrrolidines and combination preparations containing them for treating hyperlipidemia and associated diseases
08/09/2011	CA2431083C Inflammatory cytokine release inhibitor
08/04/2011	WO2011094545A2 Compositions and methods for enhancing proteasome activity
08/04/2011	WO2011092671A1 Proline derivatives for use in the treatment of diabetes
08/04/2011	WO2011091548A1 Method for cucurbitine synthesis
08/04/2011	WO2010151852A3 Protease inhibitors, compositions and methods of use
08/04/2011	US20110190511 Methods For Preparing Fluoroalkyl Arylsulfinyl Compounds And Fluorinated Compounds Thereto
08/04/2011	US20110190497 Process for production of 2,5 dioxopyrrolidine 3 carboxylate
08/04/2011	US20110190369 Substituted Pyrrole Derivatives and Their Use as HMG-CO Inhibitors
08/04/2011	US20110190325 Compounds, their syntheses, and thier uses
08/04/2011	US20110190296 Substituted Pyrrole Derivatives and Their Use as HMG-CO Inhibitors

1 ... 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 ... 404